Clinical Trial Update: Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating the safety of neoadjuvant palbociclib in combination with endocrine therapy for breast cancer. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)

Snippet

Sponsor: University of Nebraska | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING